查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1334021

體外診斷(IVD) 試劑市場：按類型（抗體、蛋白質、寡核甘酸、核酸探針）按技術（免疫測定、生物化學、分子診斷、微生物學、血液學）按應用（臨床、RUO）按最終用戶- 世界預測2030年

In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes) Technology (Immunoassay, Biochemistry, Molecular Diagnostic, Microbiology, Hematology) Use (Clinical, RUO) End User - Global Forecast to 2030
出版日期: | 出版商: Meticulous Research | 英文 389 Pages | 訂單完成後即時交付

價格

預計到 2030 年，全球體外診斷 (IVD) 試劑市場將達到 756.7 億美元，2023 年至 2030 年復合年增長率為 5.4%。

本報告經過廣泛的二級和一級研究以及對市場情景的詳細分析，分析了關鍵的行業驅動因素、抑制因素、挑戰和機遇。 該市場的增長是由傳染病的日益流行、研究活動資金的增加、先進診斷技術的日益採用、蛋白質組學和基因組學研究的增加以及提供先進診斷測試菜單的臨床實驗室數量的增加所推動的。約增加。 此外，新興國家和對蛋白質療法和個性化藥物不斷增長的需求預計將提供重大的市場增長機會。

然而，對抗原特異性試劑的嚴格監管正在限制該市場的增長。 此外，高昂的試劑成本和不利的報銷情況對市場增長構成了重大挑戰。

目錄

第一章簡介

第二章研究方法

第 3 章執行摘要

第 4 章市場洞察

    市場
  • 摘要
  • 影響市場增長的因素
    • 促進因素
      • 傳染病患病率不斷上升
      • 增加對研究活動的資助
      • 蛋白質組學和基因組學研究的增加
      • 提供先進診斷測試菜單的臨床實驗室數量增加
    • 抑制因素
      • 對抗原特異性試劑的嚴格規定
    • 機會
      • 對蛋白質療法和個性化藥物的需求不斷增加
      • 新興經濟體
    • 作業
      • 試劑成本高，報銷情況不利
    • 因素分析
  • 監管分析
    • 美國
    • 加拿大
    • 歐洲
    • 中國
    • 日本
    • 印度
    • 拉丁美洲
    • 中東/非洲
  • 波特五力分析
  • 價格分析

第五章體外診斷（IVD）試劑市場按類型評估

  • 摘要
  • 抗體
    • 抗體市場：按類型
      • 單克隆抗體
      • 多克隆抗體
    • 抗體市場：按目標分類
      • 分化簇 (CD)
      • T 細胞受體 (TCR)
      • 表皮生長因子受體 (EGFR)
      • 其他目標
  • 純化的蛋白質和□
  • 寡核甘酸
  • 核酸探針
  • 其他體外診斷藥物

第六章體外診斷（IVD）試劑市場：技術評估

  • 摘要
  • 免疫測定/免疫化學
    • □聯免疫吸附測定 (ELISA) 和□聯免疫斑點測定 (ELISpot)
    • 側流分析/快速測試
    • 蛋白質印跡法
    • 免疫熒光 (IF)
    • 功能測定
    • 免疫沉澱
    • 其他免疫分析技術
  • 生物化學/臨床化學
  • 分子診斷
    • 聚合□鍊式反應 (PCR)
    • 雜交
    • 等溫核酸擴增技術
    • DNA 測序和下一代測序
    • 微陣列芯片
    • 其他分子診斷技術
  • 微生物學
  • 血液學
  • 凝血/止血
  • 尿液測試
  • 其他 IVD 技術

第七章體外診斷（IVD）試劑市場的應用評估

  • 摘要
  • 臨床應用
  • 僅供研究 (RUO)
  • 分析物特異性試劑 (ASR)

第八章體外診斷 (IVD) 試劑市場評估：按最終用戶劃分

  • 摘要
  • 體外診斷藥物生產商
  • 參考實驗室
  • 學術機構/研究機構
  • 酒店業研究所

第九章體外診斷（IVD）試劑市場區域評估

  • 摘要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 瑞士
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 新加坡
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 中東/非洲

第10章競爭分析

  • 摘要
  • 競爭基準測試
  • 競爭對手儀表板
    • 行業領導者
    • 市場差異化因素
    • 先鋒
    • 新興公司
  • 市場份額分析（2022 年）
    • 賽默飛世爾科技（美國）
    • 默克公司（德國）
    • Becton, Dickinson and Company（美國）

第 11 章公司簡介（業務概覽、財務概覽、產品組合、戰略發展）

  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • Merck KGaA
  • Beckman Coulter, Inc.（A subsidiary of Danaher Corporation）
  • Hologic, Inc.
  • Abcam Plc.
  • Bio-Techne Corporation
  • Bio-Synthesis Inc.
  • Raybiotech, Inc.
  • SDIX, LLC.（A subsidiary of Origene Technologies, Inc.）
  • Sino Biological Inc.
  • Oy Medix Biochemica Ab
  • InBios International, Inc.

（注：將提供前5名公司的SWOT分析）

第12章附錄

Product Code: MRHC - 104414

The global in-vitro diagnostics reagents market is projected to reach $75.67 billion by 2030, at a CAGR of 5.4% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report analyzes key industry drivers, restraints, challenges, and opportunities. The growth of this market is driven by the increasing prevalence of infectious diseases, increasing funding for research activities, the rising adoption of advanced diagnostic technologies, the growth in proteomics and genomics research studies, and the growing number of clinical laboratories offering advanced diagnostic testing menus. Additionally, emerging economies and the growing demand for protein therapeutics and personalized medicines are expected to offer significant market growth opportunities.

However, the stringent regulations for antigen-specific reagents restrain the growth of this market. Additionally, the high costs of reagents and the unfavorable reimbursement scenario pose a significant challenge to the market's growth.

Based on type, the IVD reagents market is segmented into antibodies, purified proteins and peptides, oligonucleotides, nucleic acid probes, and other reagents. In 2023, the antibodies segment is expected to account for the largest share of the IVD reagents market. The large share of this segment is mainly attributed to the increasing R&D funding. For instance, According to Research America, investments in medical and health R&D by the U.S. has increased by 7.0% between 2019 and 2020. In 2020, the total medical and health R&D expenditure was USD 245.1 billion. Furthermore, the huge demand for antibodies in various biomedical & basic research are the factors contributing to the largest share of this segment.

Based on technology, the IVD reagents market is segmented into immunoassay/immunochemistry, biochemistry/clinical chemistry, molecular diagnostics, microbiology, hematology, coagulation/hemostasis, urinalysis, and other IVD technologies. In 2023, the immunoassay/immunochemistry segment is expected to account for the largest share of the IVD reagents market. The large share of this segment is mainly attributed to the increasing use of immunoassays in infectious disease testing, the development of novel tests, and the rising demand for immunoassay-based tests. Further, the coronavirus (COVID-19) outbreak since December 2019 is expected to accelerate the growth of this segment owing to the national emergency declared and the requirement of various reagents for the kits and assay preparation.

Based on the use, the IVD reagents market is segmented into clinical use, research use only (RUO), and analyte-specific reagents (ASR). In 2023, the clinical use segment is expected to account for the largest share of the IVD reagents market. The large share of this segment is mainly attributed to the growing need for the early detection of various epidemic and pandemic infections, the large volume of test samples diagnosed for clinical purposes, and initiatives undertaken by manufacturers to develop advanced IVD reagents drive the demand for IVD reagents for clinical use.

Based on the end user, the IVD reagents market is segmented into IVD manufacturers, reference laboratories, academic institutes and research laboratories, and hospital laboratories. In 2023, the IVD manufacturers segment is expected to account for the largest share of the IVD reagents market. The large share of this segment is mainly attributed to the initiatives undertaken by IVD manufacturers and the increasing demand for pharmaceutical & biopharmaceutical products from emerging countries.

An in-depth analysis of the geographic scenario of IVD reagents provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is estimated to account for the largest share of the IVD reagents market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Furthermore, in 2023, the U.S. is expected to account for the largest share of the IVD reagents market in North America. The market growth in the U.S. is attributed to the increasing prevalence of infectious diseases, growing preference for PoC testing and personalized medicine, and rising funds and investments for research reagents.

Some of the key players operating in the IVD reagents market report are Thermo Fisher Scientific (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Abcam plc (U.K.), Hologic Inc. (U.S.), InBios International, Inc. (U.S.), SDIX, LLC (U.S.), Bio Techne Corporation (U.S.), Bio-Synthesis Inc. (U.S.), RayBiotech, Inc. (U.S.), Sino Biological Inc. (China), Oy Medix Biochemica Ab (Finland), QIAGEN N.V. (Netherlands), and Beckman Coulter, Inc. (U.S.).

Scope of the Report:

IVD Reagents Market Size & Trend Analysis-by Type

  • Antibodies
    • Antibodies Market, By Type
  • Monoclonal Antibodies
  • Polyclonal Antibodies
    • Antibodies Market, By Target
  • Cluster of Differentiation (CD)
  • T-cell Receptor (TCR)
  • Epidermal Growth Factor Receptor (EGFR)
  • Other Targets
  • Purified Proteins and Peptides
  • Oligonucleotides
  • Nucleic Acid Probes
  • Other Reagents

Notes: 1. Other targets include Nucleic BCMA, DLL/Notch, EpCAM, HER2, PDGFRα, Claudin 18.2, SLAMF7, and DKK1. B-cell maturation antigen (BCMA).

2. Other reagents include blocking agents, detergents, surfactants, wetting agents, buffers, stabilizers, purified water, dyes, standards and controls, enzymes, cell culture reagents, and anti-coagulants.

IVD Reagents Market Size & Trend Analysis-by Technology

  • Immunoassay/Immunochemistry
    • Enzyme-linked Immunosorbent Assays (ELISA) and Enzyme-linked Immunospot Assays (ELISpot)
    • Lateral Flow Assays (LFA)/Rapid Tests
    • Western Blotting (WB)
    • Immunofluorescence (IF)
    • Functional Assays
    • Immunoprecipitation (IP)
    • Other Immunoassay Technologies
  • Biochemistry/Clinical Chemistry
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • Hybridization
    • Isothermal Nucleic Acid Amplification Technology
    • DNA Sequencing & Next-generation Sequencing
    • Microarray
    • Other Molecular Diagnostic Technologies
  • Microbiology
  • Hematology
  • Coagulation/Hemostasis
  • Urinalysis
  • Other IVD Technologies

Note: 1. Other technologies include virus neutralization tests, agar gel immunodiffusion, and radioimmunoassay.

2. Other molecular diagnostic technologies include electrophoresis, ligase chain reaction (LCR), northern blot, and southern blot.

3. Other IVD technologies include anatomical pathology, histochemistry, and whole blood glucose monitoring.

IVD Reagents Market Size & Trend Analysis-by Use

  • Clinical Use
  • Research Use Only (RUO)
  • Analyte-specific Reagents (ASR)

IVD Reagents Market Size & Trend Analysis-by End User

  • Reference Laboratories
  • IVD Manufacturers
  • Academic Institutes and Research Laboratories
  • Hospital Laboratories

IVD Reagents Market Size & Trend Analysis-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • Switzerland
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Singapore
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Drivers
      • 4.2.1.1. Increasing Prevalence of Infectious Diseases
      • 4.2.1.2. Increasing Funding for Research Activities
      • 4.2.1.3. Growth in Proteomics and Genomics Research Studies
      • 4.2.1.4. Growing Number of Clinical Laboratories Offering Advanced Diagnostic Testing Menus
    • 4.2.2. Restraints
      • 4.2.2.1. Stringent Regulations for Antigen-Specific Reagents
    • 4.2.3. Opportunities
      • 4.2.3.1. Growing Demand for Protein Therapeutics and Personalized Medicines
      • 4.2.3.2. Emerging Economies
    • 4.2.4. Challenges
      • 4.2.4.1. High Costs of Reagents and the Unfavorable Reimbursement Scenario
    • 4.2.5. Factor Analysis
  • 4.3. Regulatory Analysis
    • 4.3.1. U.S.
    • 4.3.2. Canada
    • 4.3.3. Europe
    • 4.3.4. China
    • 4.3.5. Japan
    • 4.3.6. India
    • 4.3.7. Latin America
    • 4.3.8. Middle East & Africa
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Buyers
    • 4.4.2. Bargaining Power of Suppliers
    • 4.4.3. Threat of Substitutes
    • 4.4.4. Threat of New Entrants
    • 4.4.5. Degree of Competition
  • 4.5. Pricing Analysis

5. In Vitro Diagnostic (IVD) Reagents Market Assessment-by Type

  • 5.1. Overview
  • 5.2. Antibodies
    • 5.2.1. Antibodies Market, by Type
      • 5.2.1.1. Monoclonal Antibodies
      • 5.2.1.2. Polyclonal Antibodies
    • 5.2.2. Antibodies Market, by Target
      • 5.2.2.1. Cluster of Differentiation (CD)
      • 5.2.2.2. T-Cell Receptor (TCR)
      • 5.2.2.3. Epidermal Growth Factor Receptor (EGFR)
      • 5.2.2.4. Other Targets
  • 5.3. Purified Proteins and Peptides
  • 5.4. Oligonucleotides
  • 5.5. Nucleic Acid Probes
  • 5.6. Other IVD Reagents

6. In Vitro Diagnostic (IVD) Reagents Market Assessment-by Technology

  • 6.1. Overview
  • 6.2. Immunoassay/Immunochemistry
    • 6.2.1. Enzyme-Linked Immunosorbent Assays (ELISA) and Enzyme-Linked Immunospot Assays (ELISpot)
    • 6.2.2. Lateral Flow Assays/Rapid Tests
    • 6.2.3. Western Blotting
    • 6.2.4. Immunofluorescence (IF)
    • 6.2.5. Functional Assays
    • 6.2.6. Immunoprecipitation
    • 6.2.7. Other Immunoassay Technologies
  • 6.3. Biochemistry/Clinical Chemistry
  • 6.4. Molecular Diagnostics
    • 6.4.1. Polymerase Chain Reaction (PCR)
    • 6.4.2. Hybridization
    • 6.4.3. Isothermal Nucleic Acid Amplification Technology
    • 6.4.4. DNA Sequencing & Next-generation Sequencing
    • 6.4.5. Microarrays
    • 6.4.6. Other Molecular Diagnostic Technologies
  • 6.5. Microbiology
  • 6.6. Hematology
  • 6.7. Coagulation/Hemostasis
  • 6.8. Urinalysis
  • 6.9. Other IVD Technologies

7. In Vitro Diagnostic Reagents Market Assessment-by Use

  • 7.1. Overview
  • 7.2. Clinical Use
  • 7.3. Research Use Only (RUO)
  • 7.4. Analyte-Specific Reagents (ASR)

8. In Vitro Diagnostic Reagents Market Assessment-by End User

  • 8.1. Overview
  • 8.2. IVD Manufacturers
  • 8.3. Reference Laboratories
  • 8.4. Academic Institutes & Research Laboratories
  • 8.5. Hospital Laboratories

9. In Vitro Diagnostic Reagents Market Assessment-by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Switzerland
    • 9.3.7. Netherlands
    • 9.3.8. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. South Korea
    • 9.4.5. Australia
    • 9.4.6. Singapore
    • 9.4.7. Rest of Asia-Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America
  • 9.6. Middle East & Africa

10. Competition Analysis

  • 10.1. Overview
  • 10.2. Competitive Benchmarking
  • 10.3. Competitive Dashboard
    • 10.3.1. Industry Leaders
    • 10.3.2. Market Differentiators
    • 10.3.3. Vanguards
    • 10.3.4. Emerging Companies
  • 10.4. Market Share Analysis (2022)
    • 10.4.1. Thermo Fisher Scientific (U.S.)
    • 10.4.2. Merck KGaA (Germany)
    • 10.4.3. Becton, Dickinson and Company (U.S.)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 11.1. Thermo Fisher Scientific Inc.
  • 11.2. Becton, Dickinson and Company
  • 11.3. Bio-Rad Laboratories, Inc.
  • 11.4. Agilent Technologies, Inc.
  • 11.5. QIAGEN N.V.
  • 11.6. Merck KGaA
  • 11.7. Beckman Coulter, Inc. (A subsidiary of Danaher Corporation)
  • 11.8. Hologic, Inc.
  • 11.9. Abcam Plc.
  • 11.10. Bio-Techne Corporation
  • 11.11. Bio-Synthesis Inc.
  • 11.12. Raybiotech, Inc.
  • 11.13. SDIX, LLC. (A subsidiary of Origene Technologies, Inc.)
  • 11.14. Sino Biological Inc.
  • 11.15. Oy Medix Biochemica Ab
  • 11.16. InBios International, Inc.

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports
  • Table 1 Percentage of the Population Aged 65 Years or above, by Region, 2022 Vs 2030 Vs 2050
  • Table 2 Human Immunodeficiency Virus (HIV) Statistics, 2022
  • Table 3 Health Expenditure, by Country
  • Table 4 Regulatory Authorities Governing In Vitro Diagnostics, by Country
  • Table 5 China: IVD Reagents Classification
  • Table 6 IVD Reagent Registration/Filing in China
  • Table 7 IVD Reagents Price List
  • Table 8 Global In-Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 9 Global Antibodies Market, by Country/Region, 2021-2030 (USD Million)
  • Table 10 Global Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 11 Key Companies Offering Monoclonal Antibodies for IVD
  • Table 12 Global Monoclonal Antibodies Market, by Country/Region, 2021-2030 (USD Million)
  • Table 13 Key Companies Offering Polyclonal Antibodies for IVD
  • Table 14 Global Polyclonal Antibodies Market, by Country/Region, 2021-2030 (USD Million)
  • Table 15 Global Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 16 Key Companies Offering CD Antibodies for IVD
  • Table 17 Global CD Antibodies Market, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Key Companies Offering TCR Antibodies
  • Table 19 Global TCR Antibodies Market, by Country/Region, 2021-2030 (USD Million)
  • Table 20 Key Companies Offering EGFR Antibodies
  • Table 21 Global EGFR Antibodies Market, by Country/Region, 2021-2030 (USD Million)
  • Table 22 Global Other Target Antibodies Market, by Country/Region, 2021-2030 (USD Million)
  • Table 23 Key Companies Offering Purified Proteins
  • Table 24 Global Purified Proteins and Peptides Market, by Country/Region, 2021-2030 (USD Million)
  • Table 25 Key Companies Offering Oligonucleotides
  • Table 26 Global Oligonucleotides Market, by Country/Region, 2021-2030 (USD Million)
  • Table 27 Key Companies Offering Nucleic Acid Probes
  • Table 28 Global Nucleic Acid Probes Market, by Country/Region, 2021-2030 (USD Million)
  • Table 29 Global Other IVD Reagents Market, by Country/Region, 2021-2030 (USD Million)
  • Table 30 Global In-Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 31 Global IVD Reagents Market for Immunoassay/Immunochemistry, by Type, 2021-2030 (USD Million)
  • Table 32 Global IVD Reagents Market for Immunoassay/Immunochemistry, by Country/Region, 2021-2030 (USD Million)
  • Table 33 Global IVD Reagents Market for ELISA and ELISpot, by Country/Region, 2021-2030 (USD Million)
  • Table 34 Global IVD Reagents Market for Lateral Flow Assays/Rapid Tests, by Country/Region, 2021-2030 (USD Million)
  • Table 35 Global IVD Reagents Market for Western Blotting, by Country/Region, 2021-2030 (USD Million)
  • Table 36 Global IVD Reagents Market for Immunofluorescence, by Country/Region, 2021-2030 (USD Million)
  • Table 37 Global IVD Reagents Market for Functional Assays, by Country/Region, 2021-2030 (USD Million)
  • Table 38 Global IVD Reagents Market for Immunoprecipitation, by Country/Region, 2021-2030 (USD Million)
  • Table 39 Global IVD Reagents Market for Other Technologies, by Country/Region, 2021-2030 (USD Million)
  • Table 40 Global IVD Reagents Market for Biochemistry/Clinical Chemistry, by Country/Region, 2021-2030 (USD Million)
  • Table 41 Global IVD Reagents Market for Molecular Diagnostics, by Type, 2021-2030 (USD Million)
  • Table 42 Global IVD Reagents Market for Molecular Diagnostics, by Country/Region, 2021-2030 (USD Million)
  • Table 43 Global IVD Reagents Market for Polymerase Chain Reaction, by Country/Region, 2021-2030 (USD Million)
  • Table 44 Global IVD Reagents Market for Hybridization, by Country/Region, 2021-2030 (USD Million)
  • Table 45 Global IVD Reagents Market for Isothermal Nucleic Acid Amplification Technology, by Country/Region, 2021-2030 (USD Million)
  • Table 46 Global IVD Reagents Market for DNA Sequencing & Next-Generation Sequencing, by Country/Region, 2021-2030 (USD Million)
  • Table 47 Global IVD Reagents Market for Microarrays, by Country/Region, 2021-2030 (USD Million)
  • Table 48 Global IVD Reagents Market for Other Molecular Diagnostics Technologies, by Country/Region, 2021-2030 (USD Million)
  • Table 49 Global IVD Reagents Market for Microbiology, by Country/Region, 2021-2030 (USD Million)
  • Table 50 Global IVD Reagents Market for Hematology, by Country/Region, 2021-2030 (USD Million)
  • Table 51 Global IVD Reagents Market for Coagulation/Hemostasis, by Country/Region, 2021-2030 (USD Million)
  • Table 52 Global IVD Reagents Market for Urinalysis, by Country/Region, 2021-2030 (USD Million)
  • Table 53 Global IVD Reagents Market for Other IVD Technologies, by Country/Region, 2021-2030 (USD Million)
  • Table 54 Global In-Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 55 Global Clinical Use IVD Reagents Market, by Country/Region, 2021-2030 (USD Million)
  • Table 56 Global Research Use Only (RUO) IVD Reagents Market, by Country/Region, 2021-2030 (USD Million)
  • Table 57 Global Analyte-Specific Reagents Market, by Country/Region, 2021-2030 (USD Million)
  • Table 58 Global In-Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 59 Global IVD Reagents Market for IVD Manufacturers, by Country/Region, 2021-2030 (USD Million)
  • Table 60 Global IVD Reagents Market for Reference Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 61 Global IVD Reagents Market Size for Academic Institutes & Research Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 62 Global IVD Reagents Market Size for Hospital Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 63 Global In Vitro Diagnostic Reagents Market, by Country/Region, 2021-2030 (USD Million)
  • Table 64 North America: In Vitro Diagnostic Reagents Market, by Country, 2021-2030 (USD Million)
  • Table 65 North America: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 66 North America: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 67 North America: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 68 North America: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 69 North America: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 70 North America: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 71 North America: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 72 North America: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 73 U.S.: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 74 U.S.: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 75 U.S.: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 76 U.S.: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 77 U.S.: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 78 U.S.: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 79 U.S.: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 80 U.S.: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 81 Canada: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 82 Canada: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 83 Canada: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 84 Canada: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 85 Canada: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 86 Canada: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 87 Canada: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 88 Canada: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 89 Europe: In Vitro Diagnostic Reagents Market, by Country, 2021-2030 (USD Million)
  • Table 90 Europe: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 91 Europe: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 92 Europe: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 93 Europe: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 94 Europe: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 95 Europe: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 96 Europe: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 97 Europe: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 98 Germany: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 99 Germany: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 100 Germany: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 101 Germany: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 102 Germany: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 103 Germany: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 104 Germany: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 105 Germany: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 106 France: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 107 France: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 108 France: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 109 France: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 110 France: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 111 France: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 112 France: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 113 France: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 114 U.K.: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 115 U.K.: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 116 U.K.: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 117 U.K.: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 118 U.K.: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 119 U.K.: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 120 U.K.: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 121 U.K.: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 122 Italy: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 123 Italy: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 124 Italy: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 125 Italy: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 126 Italy: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 127 Italy: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 128 Italy: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 129 Italy: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 130 Spain: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 131 Spain: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 132 Spain: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 133 Spain: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 134 Spain: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 135 Spain: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 136 Spain: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 137 Spain: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 138 Switzerland: Number of New Cancer Cases (2020 Vs 2030)
  • Table 139 Switzerland: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 140 Switzerland: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 141 Switzerland: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 142 Switzerland: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 143 Switzerland: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 144 Switzerland: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 145 Switzerland: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 146 Switzerland: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 147 Netherlands: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 148 Netherlands: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 149 Netherlands: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 150 Netherlands: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 151 Netherlands: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 152 Netherlands: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 153 Netherlands: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 154 Netherlands: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 155 Rest of Europe: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 156 Rest of Europe: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 157 Rest of Europe: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 158 Rest of Europe: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 159 Rest of Europe: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 160 Rest of Europe: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 161 Rest of Europe: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 162 Rest of Europe: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 163 Asia-Pacific: In Vitro Diagnostic Reagents Market, by Country, 2021-2030 (USD Million)
  • Table 164 Asia-Pacific: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 165 Asia-Pacific: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 166 Asia-Pacific: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 167 Asia-Pacific: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 168 Asia-Pacific: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 169 Asia-Pacific: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 170 Asia-Pacific: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 171 Asia-Pacific: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 172 China: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 173 China: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 174 China: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 175 China: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 176 China: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 177 China: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 178 China: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 179 China: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 180 Japan: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 181 Japan: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 182 Japan: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 183 Japan: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 184 Japan: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 185 Japan: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 186 Japan: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 187 Japan: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 188 India: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 189 India: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 190 India: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 191 India: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 192 India: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 193 India: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 194 India: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 195 India: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 196 South Korea: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 197 South Korea: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 198 South Korea: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 199 South Korea: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 200 South Korea: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 201 South Korea: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 202 South Korea: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 203 South Korea: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 204 Australia: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 205 Australia: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 206 Australia: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 207 Australia: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 208 Australia: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 209 Australia: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 210 Australia: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 211 Australia: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 212 Singapore: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 213 Singapore: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 214 Singapore: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 215 Singapore: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 216 Singapore: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 217 Singapore: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 218 Singapore: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 219 Singapore: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 220 Rest of Asia-Pacific: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 221 Rest of Asia-Pacific: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 222 Rest of Asia-Pacific: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 223 Rest of Asia-Pacific: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 224 Rest of Asia-Pacific: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 225 Rest of Asia-Pacific: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 226 Rest of Asia-Pacific: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 227 Rest of Asia-Pacific: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 228 Latin America: In Vitro Diagnostic Reagents Market, by Country, 2021-2030 (USD Million)
  • Table 229 Latin America: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 230 Latin America: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 231 Latin America: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 232 Latin America: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 233 Latin America: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 234 Latin America: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 235 Latin America: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 236 Latin America: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 237 Brazil: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 238 Brazil: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 239 Brazil: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 240 Brazil: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 241 Brazil: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 242 Brazil: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 243 Brazil: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 244 Brazil: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 245 Mexico: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 246 Mexico: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 247 Mexico: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 248 Mexico: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 249 Mexico: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 250 Mexico: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 251 Mexico: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 252 Mexico: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 253 People (20-79 Years) with Diabetes in Argentina, Colombia, and Chile (In Thousands)
  • Table 254 Rest of Latin America: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 255 Rest of Latin America: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 256 Rest of Latin America: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 257 Rest of Latin America: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 258 Rest of Latin America: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 259 Rest of Latin America: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 260 Rest of Latin America: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 261 Rest of Latin America: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)
  • Table 262 Middle East & Africa: In Vitro Diagnostic Reagents Market, by Technology, 2021-2030 (USD Million)
  • Table 263 Middle East & Africa: Immunoassay/Immunochemistry Market, by Type, 2021-2030 (USD Million)
  • Table 264 Middle East & Africa: Molecular Diagnostics Market, by Type, 2021-2030 (USD Million)
  • Table 265 Middle East & Africa: In Vitro Diagnostic Reagents Market, by Type, 2021-2030 (USD Million)
  • Table 266 Middle East & Africa: Antibodies Market, by Type, 2021-2030 (USD Million)
  • Table 267 Middle East & Africa: Antibodies Market, by Target, 2021-2030 (USD Million)
  • Table 268 Middle East & Africa: In Vitro Diagnostic Reagents Market, by Use, 2021-2030 (USD Million)
  • Table 269 Middle East & Africa: In Vitro Diagnostic Reagents Market, by End User, 2021-2030 (USD Million)